{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T02:00:26Z","timestamp":1773021626011,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T00:00:00Z","timestamp":1652918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T00:00:00Z","timestamp":1652918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Adenoid cystic carcinoma (AdCC) of the breast is a rare indolent carcinoma of salivary gland-type tumors, frequently associated with MYB genetic alteration. Solid and basaloid adenoid cystic carcinoma (SB-AdCC) is considered a sparse variant of AdCC. This study sought to search for clinicopathological and genomic features in SB-AdCC. Registered clinicopathological data on a cohort of 13 AdCC of the breast cases, including six conventional adenoid cystic carcinoma (C-AdCC) cases and seven SB-AdCC cases, were collected. MYB gene rearrangement via fluorescent in situ hybridization was investigated and MYB protein expression was evaluated by immunohistochemistry. Compared with C-AdCC, we found that the distribution of SB-AdCC cases were shifted to older age and were more frequently distant metastasis. Moreover, metastasis cases also showed a high (exceed 30%) Ki-67 index. Both groups showed MYB rearrangements and MYB protein expression, but they were less frequent in SB-AdCC than C-AdCC. To conclude, our results suggest that SB-AdCC is an aggressive variant of mammary AdCC with a higher incidence of distant metastases compared with C-AdCC, though they share common molecular features. A high Ki-67 index may be an adverse prognostic factor for metastasis.<\/jats:p>","DOI":"10.1038\/s41598-022-12583-w","type":"journal-article","created":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T19:02:55Z","timestamp":1652986975000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Distinct clinicopathological and genomic features in solid and basaloid adenoid cystic carcinoma of the breast"],"prefix":"10.1038","volume":"12","author":[{"given":"Juan","family":"Ji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanglei","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiong","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingsong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,19]]},"reference":[{"key":"12583_CR1","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/path.4573","volume":"237","author":"LG Martelotto","year":"2015","unstructured":"Martelotto, L. G. et al. Genomic landscape of adenoid cystic carcinoma of the breast. J. Pathol. 237, 179\u2013189 (2015).","journal-title":"J. Pathol."},{"key":"12583_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijscr.2015.03.010","volume":"11","author":"CE Ng","year":"2015","unstructured":"Ng, C. E., Angamuthu, N. & Fasih, T. Rare breast malignancies and review of literature: A single centres experience. Int. J. Surg. Case Rep. 11, 11\u201317 (2015).","journal-title":"Int. J. Surg. Case Rep."},{"key":"12583_CR3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/path.2974","volume":"226","author":"D Wetterskog","year":"2012","unstructured":"Wetterskog, D. et al. Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers. J. Pathol. 226, 84\u201396 (2012).","journal-title":"J. Pathol."},{"issue":"6","key":"12583_CR4","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/S0002-9610(02)00858-9","volume":"183","author":"JH McClenathan","year":"2002","unstructured":"McClenathan, J. H. & de la Roza, G. Adenoid cystic breast cancer. Am. J. Surg. 183(6), 646\u2013649 (2002).","journal-title":"Am. J. Surg."},{"key":"12583_CR5","doi-asserted-by":"publisher","first-page":"732","DOI":"10.12998\/wjcc.v2.i12.732","volume":"2","author":"K Miyai","year":"2014","unstructured":"Miyai, K. et al. Adenoid cystic carcinoma of breast: Recent advances. World J. Clin. Cases 2, 732\u2013741 (2014).","journal-title":"World J. Clin. Cases"},{"key":"12583_CR6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/00000478-200204000-00002","volume":"26","author":"SJ Shin","year":"2002","unstructured":"Shin, S. J. & Rosen, P. P. Solid variant of mammary adenoid cystic carcinoma with basaloid features: A study of nine cases. Am. J. Surg. Pathol. 26, 413\u2013420 (2002).","journal-title":"Am. J. Surg. Pathol."},{"key":"12583_CR7","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1016\/j.humpath.2014.07.013","volume":"45","author":"TM D'Alfonso","year":"2014","unstructured":"D\u2019Alfonso, T. M. et al. MYB-NFIB gene fusion in adenoid cystic carcinoma of the breast with special focus paid to the solid variant with basaloid features. Hum. Pathol. 45, 2270\u20132280 (2014).","journal-title":"Hum. Pathol."},{"key":"12583_CR8","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1097\/PAS.0000000000001378","volume":"44","author":"E Slodkowska","year":"2020","unstructured":"Slodkowska, E. et al. Predictors of outcome in mammary adenoid cystic carcinoma: A Multi-Institutional Study. Am. J. Surg. Pathol. 44, 214\u2013223 (2020).","journal-title":"Am. J. Surg. Pathol."},{"key":"12583_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1177\/1066896915606973","volume":"24","author":"MP Foschini","year":"2016","unstructured":"Foschini, M. P. et al. Solid variant of adenoid cystic carcinoma of the breast: A case series with proposal of a new grading system. Int. J. Surg. Pathol. 24, 97\u2013102 (2016).","journal-title":"Int. J. Surg. Pathol."},{"key":"12583_CR10","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1038\/s41379-019-0425-3","volume":"33","author":"J Mass\u00e9","year":"2020","unstructured":"Mass\u00e9, J. et al. Solid-type adenoid cystic carcinoma of the breast, a distinct molecular entity enriched in NOTCH and CREBBP mutations. Mod. Pathol. 33, 1041\u20131055 (2020).","journal-title":"Mod. Pathol."},{"key":"12583_CR11","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1097\/PAS.0000000000000878","volume":"41","author":"JS Poling","year":"2017","unstructured":"Poling, J. S. et al. MYB labeling by immunohistochemistry is more sensitive and specific for breast adenoid cystic carcinoma than MYB labeling by FISH. Am. J. Surg. Pathol. 41, 973\u2013979 (2017).","journal-title":"Am. J. Surg. Pathol."},{"key":"12583_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/path.5006","volume":"244","author":"J Kim","year":"2018","unstructured":"Kim, J. et al. MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB-NFIB fusion gene. J. Pathol. 244, 43\u2013150 (2018).","journal-title":"J. Pathol."},{"key":"12583_CR13","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/S0046-8177(87)80413-6","volume":"18","author":"JY Ro","year":"1987","unstructured":"Ro, J. Y., Silva, E. G. & Gallager, H. S. Adenoid cystic carcinoma of the breast. Hum. Pathol. 18, 1276\u20131281 (1987).","journal-title":"Hum. Pathol."},{"key":"12583_CR14","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.canrad.2009.02.009","volume":"13","author":"R Kallel","year":"2009","unstructured":"Kallel, R. et al. Carcinome ad\u00e9no\u00efde kystique du sein Adenoid cystic carcinoma of the breast. Cancer Radiother. 13, 323\u2013328 (2009).","journal-title":"Cancer Radiother."},{"key":"12583_CR15","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.prp.2017.01.021","volume":"213","author":"S Wang","year":"2017","unstructured":"Wang, S. et al. 36 cases adenoid cystic carcinoma of the breast in China: comparison with matched grade one invasive ductal carcinoma-not otherwise specified. Pathol. Res. Pract. 213, 310\u2013315 (2017).","journal-title":"Pathol. Res. Pract."},{"key":"12583_CR16","doi-asserted-by":"publisher","first-page":"R54","DOI":"10.1186\/bcr2613","volume":"12","author":"B Ghabach","year":"2010","unstructured":"Ghabach, B. et al. Adenoid cystic carcinoma of the breast in the United States (1977 to 2006): A population-based cohort study. Breast Cancer Res. 12, R54 (2010).","journal-title":"Breast Cancer Res."},{"key":"12583_CR17","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1002\/cam4.3707","volume":"10","author":"Z Huang","year":"2021","unstructured":"Huang, Z. et al. Multicentre clinicopathological study of adenoid cystic carcinoma: A report of 296 cases. Cancer Med. 10, 1120\u20131127 (2021).","journal-title":"Cancer Med."},{"key":"12583_CR18","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/bjs.18004519314","volume":"45","author":"DH Patey","year":"1958","unstructured":"Patey, D. H. & Thackray, A. C. The treatment of parotid tumours in the light of a pathological study of parotidectomy material. Br. J. Surg. 45, 477\u2013487 (1958).","journal-title":"Br. J. Surg."},{"key":"12583_CR19","doi-asserted-by":"publisher","first-page":"18740","DOI":"10.1073\/pnas.0909114106","volume":"106","author":"M Persson","year":"2009","unstructured":"Persson, M. et al. Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc. Natl. Acad. Sci. USA 106, 18740\u201318744 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"12583_CR20","first-page":"132","volume":"54","author":"P \u0160teiner","year":"2018","unstructured":"\u0160teiner, P., Pavelka, J., Vane\u010dek, T., Miesbauerov\u00e1, M. & Sk\u00e1lov\u00e1, A. Molecular methods for detection of prognostic and predictive markers in diagnosis of adenoid cystic carcinoma of the salivary gland origin. Cesk Patol. 54, 132\u2013136 (2018).","journal-title":"Cesk Patol."},{"key":"12583_CR21","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/modpathol.2011.86","volume":"24","author":"LB Brill","year":"2011","unstructured":"Brill, L. B. et al. Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms. Mod. Pathol. 24, 1169\u20131176 (2011).","journal-title":"Mod. Pathol."},{"key":"12583_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.580141","volume":"10","author":"L Di Villeneuve","year":"2021","unstructured":"Di Villeneuve, L. et al. Salivary gland carcinoma: Novel targets to overcome treatment resistance in advanced disease. Front. Oncol. 10, 580141 (2021).","journal-title":"Front. Oncol."},{"key":"12583_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-021-00931-6","author":"CJ Schwartz","year":"2021","unstructured":"Schwartz, C. J. et al. The clinical behavior and genomic features of the so-called adenoid cystic carcinomas of the solid variant with basaloid features. Mod. Pathol. https:\/\/doi.org\/10.1038\/s41379-021-00931-6 (2021).","journal-title":"Mod. Pathol."},{"issue":"10","key":"12583_CR24","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1097\/PAS.0000000000000918","volume":"41","author":"B Xu","year":"2017","unstructured":"Xu, B. et al. Predictors of outcome in adenoid cystic carcinoma of salivary glands: A clinicopathologic study with correlation between MYB fusion and protein expression. Am. J. Surg. Pathol. 41(10), 1422\u20131432 (2017).","journal-title":"Am. J. Surg. Pathol."},{"issue":"6","key":"12583_CR25","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1128\/MCB.01870-07","volume":"28","author":"JP O'Rourke","year":"2008","unstructured":"O\u2019Rourke, J. P. & Ness, S. A. Alternative RNA splicing produces multiple forms of c-Myb with unique transcriptional activities. Mol. Cell Biol. 28(6), 2091\u20132101 (2008).","journal-title":"Mol. Cell Biol."},{"issue":"6","key":"12583_CR26","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/s41379-018-0008-8","volume":"31","author":"Y Togashi","year":"2018","unstructured":"Togashi, Y. et al. MYB and MYBL1 in adenoid cystic carcinoma: Diversity in the mode of genomic rearrangement and transcripts. Mod. Pathol. 31(6), 934\u2013946 (2018).","journal-title":"Mod. Pathol."},{"key":"12583_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4132\/jptm.2018.10.12","volume":"53","author":"JH Lee","year":"2019","unstructured":"Lee, J. H. et al. PLAG1, SOX10, and Myb expression in benign and malignant salivary gland neoplasms. J. Pathol. Transl. Med. 53, 23\u201330 (2019).","journal-title":"J. Pathol. Transl. Med."},{"issue":"6","key":"12583_CR28","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/his.13708","volume":"73","author":"E Baraban","year":"2018","unstructured":"Baraban, E. et al. MYB rearrangement and immunohistochemical expression in adenomyoepithelioma of the breast: A comparison with adenoid cystic carcinoma. Histopathology 73(6), 897\u2013903 (2018).","journal-title":"Histopathology"},{"key":"12583_CR29","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1002\/jso.24702","volume":"116","author":"JL Welsh","year":"2017","unstructured":"Welsh, J. L. et al. Is axillary surgery beneficial for patients with adenoid cystic carcinoma of the breast?. J. Surg. Oncol. 116, 690\u2013695 (2017).","journal-title":"J. Surg. Oncol."},{"key":"12583_CR30","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s12282-017-0780-1","volume":"25","author":"D Treitl","year":"2018","unstructured":"Treitl, D. et al. Adenoid cystic carcinoma of the breast, 20 years of experience in a single center with review of literature. Breast Cancer 25, 28\u201333 (2018).","journal-title":"Breast Cancer"},{"key":"12583_CR31","doi-asserted-by":"publisher","first-page":"7648","DOI":"10.1038\/s41598-020-64523-1","volume":"10","author":"Q Liang","year":"2020","unstructured":"Liang, Q., Ma, D., Gao, R. F. & Yu, K. D. Effect of Ki-67 Expression levels and histological grade on breast cancer early relapse in patients with different immunohistochemical-based subtypes. Sci. Rep. 10, 7648 (2020).","journal-title":"Sci. Rep."},{"key":"12583_CR32","doi-asserted-by":"publisher","first-page":"687244","DOI":"10.3389\/fendo.2021.687244","volume":"12","author":"A Zhang","year":"2021","unstructured":"Zhang, A., Wang, X., Fan, C. & Mao, X. The Role of ki67 in evaluating neoadjuvant endocrine therapy of hormone receptor-positive breast cancer. Front. Endocrinol. 12, 687244 (2021).","journal-title":"Front. Endocrinol."},{"key":"12583_CR33","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10549-004-8693-z","volume":"87","author":"BA Millar","year":"2004","unstructured":"Millar, B. A. et al. The potential role of breast conservation surgery and adjuvant breast radiation for adenoid cystic carcinoma of the breast. Breast Cancer Res. Treat. 87, 225\u2013232 (2004).","journal-title":"Breast Cancer Res. Treat."},{"key":"12583_CR34","doi-asserted-by":"publisher","first-page":"921","DOI":"10.7863\/jum.2006.25.7.921","volume":"25","author":"JH Youk","year":"2006","unstructured":"Youk, J. H. et al. Recurrence of adenoid cystic carcinoma in the breast after lumpectomy and adjuvant therapy. J. Ultrasound Med. 25, 921\u2013924 (2006).","journal-title":"J. Ultrasound Med."},{"key":"12583_CR35","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1016\/j.ijrobp.2010.12.008","volume":"82","author":"K Khanfir","year":"2012","unstructured":"Khanfir, K. et al. Management of adenoid cystic carcinoma of the breast: A rare cancer network study. Int. J. Radiat. Oncol. Biol. Phys. 82, 2118\u20132124 (2012).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"12583_CR36","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.breast.2021.08.001","volume":"59","author":"A Gomez-Seoane","year":"2021","unstructured":"Gomez-Seoane, A., Davis, A. & Oyasiji, T. Treatment of adenoid cystic carcinoma of the breast: Is postoperative radiation getting its due credit?. Breast 59, 358\u2013366 (2021).","journal-title":"Breast"},{"key":"12583_CR37","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s10549-021-06259-8","volume":"187","author":"D Trapani","year":"2021","unstructured":"Trapani, D. et al. Benefit of adjuvant chemotherapy in patients with special histology subtypes of triple-negative breast cancer: A systematic review. Breast Cancer Res. Treat 187, 323\u2013337 (2021).","journal-title":"Breast Cancer Res. Treat"},{"key":"12583_CR38","doi-asserted-by":"publisher","first-page":"452","DOI":"10.6004\/jnccn.2020.0016","volume":"18","author":"WJ Gradishar","year":"2020","unstructured":"Gradishar, W. J. et al. Breast cancer, version 3.2020, NCCN clinical practice guidelines in oncology. J. Natl. Compr. Cancer Netw. 18, 452\u2013478 (2020).","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"2","key":"12583_CR39","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/his.14091","volume":"77","author":"PH Tan","year":"2020","unstructured":"Tan, P. H. et al. The 2019 World Health Organization classification of tumours of the breast. Histopathology 77(2), 181\u2013185 (2020).","journal-title":"Histopathology"},{"key":"12583_CR40","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1200\/JCO.19.02309","volume":"38","author":"KH Allison","year":"2020","unstructured":"Allison, K. H. et al. Estrogen and progesterone receptor testing in breast cancer: ASCO\/CAP guideline update. J. Clin. Oncol. 38, 1346\u20131366 (2020).","journal-title":"J. Clin. Oncol."},{"key":"12583_CR41","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.3390\/biom11111612","volume":"11","author":"C Boyaci","year":"2021","unstructured":"Boyaci, C., Sun, W., Robertson, S., Acs, B. & Hartman, J. Independent clinical validation of the automated ki67 scoring guideline from the international ki67 in breast cancer working group. Biomolecules 11, 1612 (2021).","journal-title":"Biomolecules"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12583-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12583-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12583-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T03:18:16Z","timestamp":1669346296000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12583-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,19]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["12583"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-12583-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,19]]},"assertion":[{"value":"19 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8504"}}